Board to consider Interim Dividend
Caplin Point Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 05, 2016, inter alia :1. To consider, approve and take on record inter alia the Unaudited Financial Results for the quarter /Half year ended December 31, 2015.2. To Consider and declare the payment of Interim dividend, if any for the Financial Year 2015-16.... Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Caplin Point Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Disclosure of Voting results of AGM (Clause 35A)
Caplin Point Laboratories Ltd has informed BSE regarding the details of Voting results at the 24th Annual General Meeting (AGM) of the Company held on November 05, 2015, under Clause 35A of Listing Agreement. Financial Results & Limited Review Report for Sept 30, 2015
Caplin Point Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015. Outcome of AGM
Caplin Point Laboratories Ltd has informed BSE that the 24th Annual General Meeting (AGM) of the Company was held on November 05, 2015. Board Intimation for Results & Closure of Trading Window
Caplin Point Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on November 05, 2015, inter alia, to consider and approve the Un-audited Financial Results of the Company for the quarter ended September 30, 2015.Accordingly, the Trading Window for dealing in the equity shares of the Company is closed for Promoters, Directors, other Connected Persons and Employees of the Company... Fixes Book Closure for Dividend & AGM
Caplin Point Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from October 31, 2015 to November 05, 2015 (both days inclusive) for the purpose of Payment of Dividend & 24th Annual General Meeting (AGM) of the Company to be held on November 05, 2015. Shareholding Pattern For September 30, 2015
Caplin Point Laboratories Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015. Caplin Point gets Brazil's Anvisa approval for Sterile Injectable Site
Caplin Point Laboratories Ltd has informed BSE regarding a Press Release dated September 03, 2015 titled "Caplin Point gets Brazil's Anvisa approval for Sterile Injectable Site". Results Press Release
Caplin Point Laboratories Ltd has submitted to BSE a copy of Results Press Release for the period ended June 30, 2015.